S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NASDAQ:FRPT

Freshpet (FRPT) Stock Forecast, Price & News

$59.76
-3.61 (-5.70%)
(As of 05/31/2023 ET)
Compare
Today's Range
$57.66
$63.48
50-Day Range
$59.73
$70.53
52-Week Range
$36.02
$73.48
Volume
1.17 million shs
Average Volume
813,394 shs
Market Capitalization
$2.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$76.31

Freshpet MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
27.7% Upside
$76.31 Price Target
Short Interest
Bearish
14.73% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-3.54
Upright™ Environmental Score
News Sentiment
0.11mentions of Freshpet in the last 14 days
Based on 18 Articles This Week
Insider Trading
Selling Shares
$440,018 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.97) to ($0.24) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

Consumer Staples Sector

131st out of 140 stocks

Grain Mill Products Industry

5th out of 5 stocks


FRPT stock logo

About Freshpet (NASDAQ:FRPT) Stock

Freshpet, Inc. engages in manufacturing, marketing, and distribution of pet food and pet treats for dogs and cats. Its products are blends of fresh meats, vegetables and fruits farmed locally and made at Freshpet kitchens. Its products include Deli Fresh Grain Free Chicken Recipe for Dogs, Joy Turkey and Apple Bites Treats, Nature's Fresh Grain Free Chicken Recipe for Cats, and Vital Grain Free Chicken and Ocean Whitefish Recipe for Cats. The company was founded by Scott Morris and Cathal Walsh in November 2004 and is headquartered in Secaucus, NJ.

Receive FRPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Freshpet and its competitors with MarketBeat's FREE daily newsletter.

FRPT Stock News Headlines

Freshpet Is On The Brink Of Reversal 
Freshpet is executing expansion plans that aim to improve operating leverage and profitability. The market is moving higher and may complete a reversal.
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Freshpet (NASDAQ: FRPT)
Freshpet: Stale Economics
Jana Prepares for Proxy Fight at Freshpet
See More Headlines
Receive FRPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Freshpet and its competitors with MarketBeat's FREE daily newsletter.

FRPT Company Calendar

Last Earnings
5/08/2023
Today
5/31/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Grain mill products
Sub-Industry
N/A
Current Symbol
NASDAQ:FRPT
Fax
N/A
Employees
1,011
Year Founded
2006

Price Target and Rating

Average Stock Price Forecast
$76.31
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$55.00
Forecasted Upside/Downside
+31.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
12 Analysts

Profitability

Net Income
$-59,490,000.00
Pretax Margin
-9.99%

Debt

Sales & Book Value

Annual Sales
$595.34 million
Book Value
$19.72 per share

Miscellaneous

Free Float
45,715,000
Market Cap
$2.79 billion
Optionable
Optionable
Beta
0.97

Social Links


Key Executives

  • William B. CyrWilliam B. Cyr
    Chief Executive Officer & Director
  • Scott Morris
    President & Chief Operating Officer
  • Todd E. Cunfer
    Chief Financial Officer
  • Gerardo Perez-Camargo
    Vice President-Research & Development
  • Jay Dahlgren
    EVP-Manufacturing, Technology & Supply Chain













FRPT Stock - Frequently Asked Questions

Should I buy or sell Freshpet stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Freshpet in the last year. There are currently 3 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" FRPT shares.
View FRPT analyst ratings
or view top-rated stocks.

What is Freshpet's stock price forecast for 2023?

12 Wall Street analysts have issued 12-month price targets for Freshpet's shares. Their FRPT share price forecasts range from $55.00 to $100.00. On average, they expect the company's share price to reach $76.31 in the next year. This suggests a possible upside of 28.5% from the stock's current price.
View analysts price targets for FRPT
or view top-rated stocks among Wall Street analysts.

How have FRPT shares performed in 2023?

Freshpet's stock was trading at $52.77 at the beginning of 2023. Since then, FRPT stock has increased by 12.6% and is now trading at $59.40.
View the best growth stocks for 2023 here
.

When is Freshpet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our FRPT earnings forecast
.

How were Freshpet's earnings last quarter?

Freshpet, Inc. (NASDAQ:FRPT) announced its quarterly earnings data on Monday, May, 8th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.40) by $0.12. The firm earned $167.50 million during the quarter, compared to analysts' expectations of $166.97 million. Freshpet had a negative net margin of 10.58% and a negative trailing twelve-month return on equity of 6.60%. The company's revenue was up 26.7% on a year-over-year basis. During the same period last year, the business earned ($0.40) earnings per share.

What guidance has Freshpet issued on next quarter's earnings?

Freshpet issued an update on its FY 2023 earnings guidance on Monday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $750.00 million-$750.00 million, compared to the consensus revenue estimate of $752.30 million.

What is William Cyr's approval rating as Freshpet's CEO?

27 employees have rated Freshpet Chief Executive Officer William Cyr on Glassdoor.com. William Cyr has an approval rating of 94% among the company's employees. This puts William Cyr in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 78.0% of employees surveyed would recommend working at Freshpet to a friend.

What other stocks do shareholders of Freshpet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Freshpet investors own include Walt Disney (DIS), Block (SQ), DocuSign (DOCU), NVIDIA (NVDA), Netflix (NFLX), Advanced Micro Devices (AMD), Etsy (ETSY), Roku (ROKU), Shopify (SHOP) and PayPal (PYPL).

What is Freshpet's stock symbol?

Freshpet trades on the NASDAQ under the ticker symbol "FRPT."

Who are Freshpet's major shareholders?

Freshpet's stock is owned by many different institutional and retail investors. Top institutional shareholders include Jana Partners LLC (8.34%), Champlain Investment Partners LLC (7.78%), Wellington Management Group LLP (7.10%), Wasatch Advisors LP (6.58%), FMR LLC (5.18%) and BlackRock Inc. (4.37%). Insiders that own company stock include Cathal Walsh, Charles A Norris, Daryl G Brewster, Ivan Garcia, Lawrence S Coben, Richard A Kassar, Robert C King, Scott James Morris, Stephen Macchiaverna, Stephen Weise, Walter N George and William B Cyr.
View institutional ownership trends
.

How do I buy shares of Freshpet?

Shares of FRPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Freshpet's stock price today?

One share of FRPT stock can currently be purchased for approximately $59.40.

How much money does Freshpet make?

Freshpet (NASDAQ:FRPT) has a market capitalization of $2.86 billion and generates $595.34 million in revenue each year. The company earns $-59,490,000.00 in net income (profit) each year or ($1.42) on an earnings per share basis.

How many employees does Freshpet have?

The company employs 1,011 workers across the globe.

How can I contact Freshpet?

Freshpet's mailing address is 400 Plaza Drive 1st Floor, Secaucus NJ, 07094. The official website for the company is www.freshpet.com. The company can be reached via phone at (201) 520-4000 or via email at katie.turner@icrinc.com.

This page (NASDAQ:FRPT) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -